Sera Prognostics, Inc. (SERA)
NASDAQ: SERA · Real-Time Price · USD
3.255
+0.005 (0.15%)
Oct 8, 2025, 11:39 AM EDT - Market open
Sera Prognostics Market Cap
Sera Prognostics has a market cap or net worth of $123.89 million as of October 8, 2025. Its market cap has decreased by -52.40% in one year.
Market Cap
123.89M
Enterprise Value
11.87M
1-Year Change
-52.40%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since the IPO on July 15, 2021, Sera Prognostics's market cap has decreased from $488.14M to $123.89M, a decrease of -74.62%. That is a compound annual growth rate of -27.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 124.08M | -54.86% |
| Dec 31, 2024 | 274.91M | 46.70% |
| Dec 29, 2023 | 187.39M | 379.49% |
| Dec 30, 2022 | 39.08M | -81.47% |
| Dec 31, 2021 | 210.90M | -56.79% |
| Jul 15, 2021 | 488.14M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |